DGAP-News: Geratherm Medical AG / Key word(s): Quarter Results Geratherm Medical AG: Strong sales and earnings growth in Q I/2015 21.05.2015 / 07:30 --------------------------------------------------------------------- Corporate News Geratherm Medical: Strong sales and earnings growth in Q I/2015 Sales revenues EUR 5.4 million +39.1% Overall performance EUR 5.6 million +40.6% Gross result for first quarter of year (EBITDA)929 kEUR +85.5% Operating result (EBIT)719 kEUR +107.8% Results from ordinary business activities 627 kEUR +109.0% Earnings after taxes (EAT) 569 kEUR +198.7% Sales by Segments: Healthcare Diagnostic: 3,696 kEUR +26.0 % Respiratory: 784 kEUR +46.5 % Med. Warming Systems: 682 kEUR +185.4 % Cardio/Stroke: 188 kEUR +34.3 % Geratherm Medical reported a strong first quarter for all product segments. Sales and earnings increased considerably. With an EBITDA margin of 17.4% and an EBIT margin of 13.4%, we exhibited a substantially healthier performance in terms of operations compared to the reference period of 2014. We are anticipating a positive development of the company for the next quarters. Short company profile: Geratherm Medical is an internationally operating medical products enterprise with the business areas Healthcare Diagnostic, Medical Warming Systems, Cardio/Stroke and Respiratory. Our company's roots are in temperature measurement in the medical sphere. In this business area we offer a broad spectrum of products, most of which have unique selling points. We supply our customers/patients with high-quality products ranging from thermometers to complex warming systems for use in the operating theatre and by emergency rescue services and MRI Diagnostic Incubator Systems for premature babies and newborns. In the Cardio business area we concentrate on the development of products for the detection of atrial fibrillation as a measure to prevent strokes. The Respiratory segment develops and markets products for the assessment of pulmonary function. In all mainly business areas, Geratherm has patent-protected basic technologies at its disposal. We regard ourselves as a research-based medical products company with a clear focus on medical diagnostic devices that generate vital data. Geratherm shares have been listed in the Prime Standard segment of the Frankfurt Stock Exchange since the year 2000. Geratherm Medical continues to be represented in the German Entrepreneurial Index and in the German Healthcare Index. Geratherm Medical AG, Investor Relations Fahrenheitstraße 1, 98716 Geschwenda Tel. +49 (0)36205/98 111, E-Mail: [email protected] www.geratherm.com Emittent: Geratherm Medical AG, Fahrenheitstraße 1, 98716 Geschwenda Deutschland Tel. 036205/98 111 Fax: 036205/98 115 --------------------------------------------------------------------- 21.05.2015 Dissemination of a Corporate News, transmitted by DGAP - a service of EQS Group AG. The issuer is solely responsible for the content of this announcement. The DGAP Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases. Media archive at www.dgap-medientreff.de and www.dgap.de --------------------------------------------------------------------- Language: English Company: Geratherm Medical AG Fahrenheitstraße 1 98716 Geschwenda Germany Phone: +49 (0)36205 98-0 Fax: +49 (0)36205 98-1 15 E-mail: [email protected] Internet: www.geratherm.com ISIN: DE0005495626 WKN: 549562 Listed: Regulated Market in Frankfurt (Prime Standard); Regulated Unofficial Market in Berlin, Dusseldorf, Hamburg, Munich, Stuttgart End of News DGAP News-Service --------------------------------------------------------------------- 359451 21.05.2015